News
$Inventiva (IVA.US)$ Japanese Patent Office Approves Inventiva's Patent For Use Of Lanifibranor In Treating Cirrhosis, Strengthening IP For MASH/NASH Indications; Patent Valid Until November 2039
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
